Methadone maintenance treatment (MMT) in general practice or in specialized centers: Profile of patients in the Swiss Canton of Vaud

American Journal of Drug and Alcohol Abuse

Volumn 33, Issue 5, 2007, Pages 665-674

  Pelet, Anne ^a,d   Doll, Sebastien ^a   Huissoud, Thérèse ^b   Resplendino, Janine ^c   Besson, Jacques ^a   Favrat, Bernard ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c Service of Public Health   (Switzerland)

^d Centre Saint Martin   (Switzerland)

Author keywords

General practitioners; Hepatitis B; Hepatitis C; HIV; Methadone maintenance treatment; Specialized centers

Indexed keywords

COCAINE; DIAMORPHINE; METHADONE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; GENERAL PRACTICE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEROIN DEPENDENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CENTER; METHADONE TREATMENT; PATIENT ASSESSMENT; PRESCRIPTION; SCREENING; VIRUS EXAMINATION;

ADULT; AIDS SERODIAGNOSIS; ANTIPSYCHOTIC AGENTS; COCAINE-RELATED DISORDERS; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; FAMILY PRACTICE; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS C; HEROIN DEPENDENCE; HUMANS; MALE; METHADONE; NARCOTICS; OPIOID-RELATED DISORDERS; PATIENT DROPOUTS; QUESTIONNAIRES; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS; SWITZERLAND;

EID: 34648812682     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.1080/00952990701522740     Document Type: Article

References (27)

1. Marsch LA. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: A meta-analysis. Addiction 1998; 93:515-532.
2. Lewis D, Bellis M. General practice or drug clinic for methadone maintenance? A controlled comparison of treatment outcomes. Int J Drug Policy 2001; 12:81-893.
3. Norvick DM, Joseph H, Salsitz EA, Kalin MF, Keefe JB, Miller EL, Richman BL. Outcomes of treatment of socially rehabilitated methadone maintenance patients in physicians' offices: Follow-up at three and a half to nine and a fourth year. J Gen Int Med 1994; 9:127-130.
4. Lewis DC. Access to narcotic addiction treatment and medical care. In Effective Medical Treatment of Heroin Addiction, NIH Consensus Conferences, United Kingdom, 1997.
5. Umbriche-Schneiter A, Ginn DH, Pabst KM, Bigelow GE. Providing medical care to methadone clinic patients: referral vs on-site care. Am J Public Health 1994; 84:207-210.
6. Swiss Federal Law on Narcotics, Art. 15. a and 5.
7. Brands B, Blake J, Marsh D. Changing patient characteristics with increased methadone maintenance availability. Drug Alcohol Depend 2002; 66:11-20.
8. Klingemann HKH. Drug treatment in Switzerland: Harm reduction, decentralization and community response. Addiction 1996; 91:723-736.
9. Meystre-Augustoni G, Wietlishbach V, Martin J, Haller-Maslov E. Methadone treatment in medical private practice: Outcome according to the number of courses followed. Br J Addict 1990; 85:537-545.
10. Gossop M, Marsden J, Stewart D, Lehmann P, Strang J. Methadone treatment practices and outcome for opiate addicts treated in drug clinics and in general practice: Results from the National Treatment Outcome Research Study. Br J Gen Pract 1999; 49:31-34.
11. Pelet A, Doll S, Huissoud T, Resplendino J, Besson J, Favrat B. Methadone maintenance treatment in the Swiss Canton of Vaud: Demographic and clinical data on 1,782 ambulatory patients. Eur Addict Res 2005; 11(2):99-106.
12. Swiss Federal Office of Statistics. 2001. Bern, Switzerland.
13. Maxwell S, Shinderman M. Optimizing response to methadone maintenance treatment: use of Higher-dose methadone. J Psychoactive Drugs 1999; 31:95-102.
14. Eap CB, Bertschy G, Finkbeiner T, Gastpar M, Scherbaum N, Baumann P. High interindividual variability of methadone enantiomer blood levels to dose ratios. Arch Gen Psychiatry 1998; 55:89-90.
15. Kreek MJ. Plasma and urine levels of methadone. N Y State J Med 1973; 73:2773-2777.
16. Joseph H, Stancliff S, Langrod J. Methadone maintenance treatment (MMT): A review of historical and clinical issues. Mt Sinai J Med 2000; 67:347-364.
17. Verster A, Buning E. Methadone guidelines, 2000. In http://www.q4q.nl/ methwork/home2.htm (Euro-Methwork)
18. Strang J, et al. Drug Misuse and Dependence: Guidelines on Clinical Management. United Kingdom, 1997.
19. Hamilton E, Humphreys K. Outpatient methadone services in the department of Veterans Affairs: Summary of Clinic survey findings. Department of Veterans Affairs Palo Alto Heath Care System, 1996.
20. Maddux JF, Prihoda TJ, Vogtsberger KN. The relationship of methadone dose and other variables to outcomes of methadone maintenance. Am J Addict 1997; 6:246-255.
21. Strain EC, Bigelow GE, Loebson IA, Stitzer ML. Moderate-vs high-dose methadone in the treatment of opioid dependence: A randomized trial. J Am Med Association 1999; 281:1000-1005.
22. Van Ameijden EJ, Langendam MW, Coutinho R. A. Dose-effect relationship between overdose mortality and prescribed methadone dosage in low-threshold maintenance programs. Addict Behav 1999; 24:559-563.
23. MacGillion J, Wanigaratne S, Feinmann C. GPs' attitudes towards the treatment of drug misusers, Br J Gen Pract 2000; 50:385-386.
24. Lewis D, Bellis M. General practice or drug clinic for methadone maintenance? A controlled comparison of treatment outcomes. Int J Drug Policy 2001; 12:81-89.
25. Cooper JR. Including narcotic addiction treatment in an office-based practice. Journal of Am Med Association 1995; 273:1619-1620.
26. Wartenberg AA. HIV disease in the intravenous drug user: Role of the primary care physician. J Gen Int Med 1991; 6:S35-S40.
27. Fitzgerald M, Barry J, O'Sullivan P, Thornton L. Blood-borne infections in Dublin's opiate users. Ir J Med Sci 2001; 170:32-34.